Show simple item record

dc.contributor.authorWhittell, Louise
dc.contributor.authorBatty, Kevin
dc.contributor.authorWong, R.
dc.contributor.authorBolitho, Erin
dc.contributor.authorFox, Simon
dc.contributor.authorDavis, T.
dc.contributor.authorMurray, Paul
dc.date.accessioned2017-01-30T15:13:08Z
dc.date.available2017-01-30T15:13:08Z
dc.date.created2011-11-27T20:00:51Z
dc.date.issued2011
dc.identifier.citationWhittell, Louise R. and Batty, Kevin T. and Wong, Rina P.M. and Bolitho, Erin M. and Fox, Simon A. and Davis, Timothy M.E. and Murray, Paul E. 2011. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives. Bioorganic & Medicinal Chemistry. 19 (24): pp. 7519-7525.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/44272
dc.identifier.doi10.1016/j.bmc.2011.10.037
dc.description.abstract

A series of mono- and di-substituted analogues of isocryptolepine have been synthesized and evaluated for in vitro antimalarial activity against chloroquine sensitive (3D7) and resistant (W2mef) Plasmodium falciparum and for cytotoxicity (3T3 cells). Di-halogenated compounds were the most potent derivatives and 8-bromo-2-chloroisocryptolepine displayed the highest selectivity index (106; the ratio of cytotoxicity (IC50 = 9005 nM) to antimalarial activity (IC50 = 85 nM)). Our evaluation of novel isocryptolepine compounds has demonstrated that di-halogenated derivatives are promising antimalarial lead compounds.

dc.publisherElsevier
dc.titleSynthesis and antimalarial evaluation of novel isocryptolepine derivatives
dc.typeJournal Article
dcterms.source.volume19
dcterms.source.startPage7519
dcterms.source.endPage7525
dcterms.source.issn0968-0896
dcterms.source.titleBioorganic & Medicinal Chemistry
curtin.departmentSchool of Pharmacy
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record